주식/증권 ➡️ 중립

Novo Nordisk strikes second licensing deal since frosty capital-markets day

MarketWatch - Top Stories 2026/09/29 09:45:00 19회

요약

Novo Nordisk on Tuesday struck its second licensing deal since receiving a poor reception from investors after presenting its long-term strategy.

원문 기사 보기

관련 뉴스

China’s CXMT makes ‘key progress’ on new chip structure: SCMP

SkyAI rejects Forward Industries bid, plans $3.00/share tender offer for up to 95% of shares

Stock index futures edge higher as investors await bank earnings, and inflation data

Fed Chair Kevin Warsh and the FOMC Just Fired a Warning Shot at the Second-Priciest Stock Market in History

뉴스 목록으로